J_2000 schreef op 24 februari 2017 07:03:
Marcel Wijma (Van Leeuwenhoek) heeft update afgegeven nav jaarcijfers 2016 en forecast 2017
Koersdoel naar 11,83 euro!
MDxHealth considerably undervalued: Increased valuation to EUR 589 million Based on NPV based valuation, we believe that MDxHealth is substantially undervalued at the current share price of EUR 5.38. Using our valuation model and taking into account the increased outlook for the future revenues of ConfirmMDx®, SelectMDx™ and AssureMDx™, and the growing income from royalties derived from its out-licensed products, we have increased our valuation from EUR 500 million to EUR 589 million, or EUR 11.83 per share (from EUR 10.00). This represents a substantial upside from the current share price.nebula.wsimg.com/7a8965587aea93f513c1...